Renaissance Technologies's CLB Position Overview
Renaissance Technologies (via Renaissance Technologies LLC) currently holds 183,400 shares of Core Laboratories Inc. (CLB) worth $2.94 M, representing 0.00% of the portfolio. First purchased in 2013-Q2, this long-term strategic position has been held for 41 quarters.
Based on 13F filings since 2013, Renaissance Technologies has maintained a long-term strategic position in CLB, representing a significant commitment to this investment thesis. Largest addition occurred in Q1 2020, adding 650,000 shares. Largest reduction occurred in Q2 2020, reducing 315,552 shares.
Analysis based on 13F filings available since 2013 Q2
Renaissance Technologies's Core Laboratories (CLB) Holding Value Over Time
Track share changes against reported price movement
Quarterly Core Laboratories (CLB) Trades by Renaissance Technologies
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q4 2025 | +149,219 | Add 436.56% | 183,400 | $16.03 |
| Q3 2025 | +34,181 | New Buy | 34,181 | $12.36 |
| Q4 2024 | -27,600 | Sold Out | 0 | $0.00 |
| Q3 2024 | +27,600 | New Buy | 27,600 | $18.53 |
| Q2 2024 | -46,300 | Sold Out | 0 | $0.00 |
| Q1 2024 | +46,300 | New Buy | 46,300 | $17.08 |
| Q1 2023 | -17,000 | Sold Out | 0 | $0.00 |
| Q4 2022 | +17,000 | New Buy | 17,000 | $0.02 |
| Q2 2022 | -138,100 | Sold Out | 0 | $0.00 |
| Q1 2022 | +41,833 | Add 43.46% | 138,100 | $31.63 |
| Q4 2021 | +96,267 | New Buy | 96,267 | $22.31 |
| Q2 2021 | -23,289 | Sold Out | 0 | $0.00 |
| Q1 2021 | -58,113 | Reduce 71.39% | 23,289 | $28.77 |
| Q4 2020 | -54,691 | Reduce 40.19% | 81,402 | $26.51 |
| Q3 2020 | -198,355 | Reduce 59.31% | 136,093 | $15.26 |
| Q2 2020 | -315,552 | Reduce 48.55% | 334,448 | $20.32 |
| Q1 2020 | +650,000 | New Buy | 650,000 | $10.34 |
| Q2 2019 | -250,700 | Sold Out | 0 | $0.00 |
| Q1 2019 | -186,600 | Reduce 42.67% | 250,700 | $68.93 |
| Q4 2018 | +274,600 | Add 168.78% | 437,300 | $59.66 |
| Q3 2018 | -121,400 | Reduce 42.73% | 162,700 | $115.83 |
| Q2 2018 | +61,800 | Add 27.80% | 284,100 | $126.21 |
| Q1 2018 | +152,100 | Add 216.67% | 222,300 | $108.22 |
| Q4 2017 | +70,200 | New Buy | 70,200 | $109.54 |
| Q3 2017 | -116,200 | Sold Out | 0 | $0.00 |
| Q2 2017 | -55,900 | Reduce 32.48% | 116,200 | $101.27 |
| Q1 2017 | +172,100 | New Buy | 172,100 | $115.52 |
| Q4 2016 | -221,900 | Sold Out | 0 | $0.00 |
| Q3 2016 | -19,400 | Reduce 8.04% | 221,900 | $112.33 |
| Q2 2016 | +241,300 | New Buy | 241,300 | $123.89 |
| Q4 2015 | -106,600 | Sold Out | 0 | $0.00 |
| Q3 2015 | -149,540 | Reduce 58.38% | 106,600 | $99.80 |
| Q2 2015 | -215,360 | Reduce 45.68% | 256,140 | $114.04 |
| Q1 2015 | +325,500 | Add 222.95% | 471,500 | $104.49 |
| Q4 2014 | +57,000 | Add 64.04% | 146,000 | $120.34 |
| Q3 2014 | -82,800 | Reduce 48.20% | 89,000 | $146.35 |
| Q2 2014 | +108,342 | Add 170.73% | 171,800 | $167.06 |
| Q1 2014 | -85,842 | Reduce 57.50% | 63,458 | $198.45 |
| Q4 2013 | -73,200 | Reduce 32.90% | 149,300 | $190.95 |
| Q3 2013 | +5,000 | Add 2.30% | 222,500 | $169.21 |
| Q2 2013 | +217,500 | Add 0.00% | 217,500 | $151.66 |
Renaissance Technologies's Core Laboratories Investment FAQs
Renaissance Technologies first purchased Core Laboratories Inc. (CLB) in Q2 2013, acquiring 217,500 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Renaissance Technologies has held Core Laboratories Inc. (CLB) for 41 quarters since Q2 2013.
Renaissance Technologies's largest addition to Core Laboratories Inc. (CLB) was in Q1 2020, adding 650,000 shares worth $6.72 M.
According to the latest 13F filing for Q4 2025, Renaissance Technologies's firm, Renaissance Technologies LLC, owns 183,400 shares of Core Laboratories Inc. (CLB), valued at approximately $2.94 M.
As of the Q4 2025 filing, Core Laboratories Inc. (CLB) represents approximately 0.00% of Renaissance Technologies's publicly disclosed stock portfolio, making it one of their key holdings.
Renaissance Technologies's peak holding in Core Laboratories Inc. (CLB) was 650,000 shares, as reported at the end of Q1 2020.